首页> 外文期刊>Drug delivery. >Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide
【24h】

Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide

机译:脯氨酸衍生物模板介孔二氧化硅的仿生合成,可增加地西epa的脑部分布并改善尼美舒利的药效学

获取原文
           

摘要

Abstract Herein a new kind of proline-derivative templated mesoporous silica with curved channels (CMS) was biomimetically synthesized and applied as carrier to improve the drug dissolution and bioavailability of hydrophobic diazepam (DZP) and nimesulide (NMS). Drugs can be incorporated into CMS with high efficiency; during this process, they successfully transformed to amorphous phase. As a result, the dissolution rate of DZP and NMS was significantly improved. Biodistribution study confirmed that CMS converted DZP distribution in mice with the tendency of lung targeting and brain targeting. At 45?min postadministration, the concentrations of DZP in plasma, lung and brain were 8.57-fold, 124.94-fold and 19.55-fold higher from 1:3 DZP/CMS sample than that of pure DZP sample, respectively. At 90?min postadministration, the content of DZP in brain was 62.31-fold higher for 1:3 DZP/CMS sample than that of pure DZP. Besides, the anti-inflammatory and analgesic effects of 1:3 NMS/CMS were systematic evaluated using mouse ankle swelling test (MAST), mouse ear swelling test (MEST) and mouse writhing test (MWT). The results indicated that after incorporating into CMS, the therapeutic effects of NMS were obviously improved, and the inhibition rates of 1:3 NMS/CMS in all pharmacodynamics tests varied from 102.2% to 904.3%.
机译:摘要本文仿生合成了一种新型的脯氨酸衍生物模板化弯曲通道介孔二氧化硅(CMS),并作为载体用于改善疏水性地西epa(DZP)和尼美舒利(NMS)的药物溶出度和生物利用度。药物可以高效地并入CMS。在此过程中,他们成功转变为非晶相。结果,DZP和NMS的溶解速率显着提高。生物分布研究证实,CMS可改变DZP在小鼠中的分布,并具有靶向肺和靶向脑的趋势。给药后45分钟,血浆,肺和脑中DZP的浓度分别比纯DZP样品高1:3 DZP / CMS样品高8.57倍,124.94倍和19.55倍。给药后90分钟,与纯DZP相比,1:3 DZP / CMS样品中脑中DZP的含量高62.31倍。此外,采用小鼠脚踝肿胀试验(MAST),小鼠耳肿胀试验(MEST)和小鼠扭体试验(MWT),系统评价了1:3 NMS / CMS的抗炎和镇痛作用。结果表明,加入CMS后,NMS的治疗效果明显改善,所有药效学试验中1:3 NMS / CMS的抑制率在102.2%至904.3%之间。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号